{
    "SPADE_N_13986": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13986",
            "Peptide Name": "Engraulisin (Synthetic AMPs, variant of Pep39, Arg-rich; cell-penetrating, UCLL1)",
            "Source": "Amino acid substitution",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RLFRHRFKRVLRL",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1797.21,
            "PI": 12.0,
            "Hydrophobicity": -0.65,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Saraswat S, Chugh A.2023",
                    "Reference": "Biochim Biophys Acta Biomembr. 2023 Nov 21:184255. doi: 10.1016/j.bbamem.2023.184255.PubMed",
                    "Title": "Engraulisin: A novel marine derived cell penetrating peptide with activity against drug resistant bacteria."
                }
            ],
            "Frequent Amino Acids": "RLF",
            "Absent Amino Acids": "ACDEGIMNOPQSTUWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 8,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (84.62%) toPep-39. R: 38%; L: 23%; F: 15%. GRAVY: -0.646; M Wt: 1797.233; M formula: C83H141N31O14, mol ex coeff: 0.Activity:  it inhibited MRSA (MIC 20 uM). SEM revealed morphological changes in MRSA after treatment.Toxicity: MTT assays: 10-100 uM, not toxic to HeLa cells.Structure:  CD spectra did not support a clear helical structure in SDS or TFE.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_02365",
                    "Similarity": 1.0,
                    "Sequence": "HMILIRLFR"
                },
                {
                    "SPADE_ID": "SPADE_UN_04104",
                    "Similarity": 1.0,
                    "Sequence": "LRLFLRHRF"
                },
                {
                    "SPADE_ID": "SPADE_UN_23051",
                    "Similarity": 1.0,
                    "Sequence": "KIAKRIWKILRRRLFR"
                }
            ]
        }
    }
}